Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  NASDAQ OMX HELSINKI LTD.  >  Revenio Group Oyj    REG1V   FI0009010912

REVENIO GROUP OYJ

(REG1V)
  Report
Real-time Estimate Quote. Real-time Estimate CHI-X - 12/03 11:25:00 am
41.475 EUR   +0.18%
12/01REVENIO GROUP CORPORATION : Managers' Transactions
AQ
11/24REVENIO GROUP CORPORATION : Managers' Transactions
AQ
11/17REVENIO GROUP CORPORATION : Managers' Transactions
AQ
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq Omx Helsinki Ltd.
11/27/2020 11/30/2020 12/01/2020 12/02/2020 12/03/2020 Date
41.1(c) 43.9(c) 41.7(c) 41.4(c) 41.25 Last
15 899 651 102 56 906 45 679 23 681 Volume
+0.24% +6.81% -5.01% -0.72% -0.36% Change
More quotes
Financials
Sales 2020 58,1 M 70,7 M 70,7 M
Net income 2020 11,9 M 14,5 M 14,5 M
Net Debt 2020 0,61 M 0,74 M 0,74 M
P/E ratio 2020 93,0x
Yield 2020 0,87%
Sales 2021 70,5 M 85,8 M 85,8 M
Net income 2021 16,5 M 20,1 M 20,1 M
Net cash position 2021 6,89 M 8,38 M 8,38 M
P/E ratio 2021 76,7x
Yield 2021 1,12%
Capitalization 1 098 M 1 327 M 1 336 M
EV / Sales 2020 18,9x
EV / Sales 2021 15,5x
Nbr of Employees 129
Free-Float 80,8%
More Financials
Company
Revenio Group Oyj, formerly Done Solutions Oyj, is a Finland-based company primarily engaged in the health technology segment. The Company’s activities are divided into two business areas: Revenio Health Tech, which is responsible for the design, manufacture and sale of tonometers and bone density measurement devices; as well as Revenio Technology and Services, which provides contact center services for material... 
More about the company
Notations Surperformance© of Revenio Group Oyj
Trading Rating : Investor Rating :
More Ratings
All news about REVENIO GROUP OYJ
12/01REVENIO GROUP CORPORATION : Managers' Transactions
AQ
11/24REVENIO GROUP CORPORATION : Managers' Transactions
AQ
11/17REVENIO GROUP CORPORATION : Managers' Transactions
AQ
11/04REVENIO GROUP CORPORATION : Increased number of shares entered into trade regist..
AQ
10/22REVENIO GROUP CORPORATION : Interim report, January 1 - September 30, 2020
AQ
10/21REVENIO GROUP CORPORATION : Revenio Group Corporation's Board of Directors estab..
AQ
10/14REVENIO GROUP CORPORATION : Notice pursuant to chapter 9, section 5 of the secur..
AQ
10/12REVENIO GROUP CORPORATION : Revenio Group Corporation's earnings guidance for th..
AQ
09/18REVENIO GROUP CORPORATION : Transfer of the Company's own shares
AQ
09/03REVENIO GROUP CORPORATION : Managers' Transactions
AQ
08/19REVENIO GROUP CORPORATION : Increased number of shares entered into trade regist..
AQ
08/07REVENIO GROUP CORPORATION : Managers' Transactions
AQ
08/06REVENIO GROUP CORPORATION : Half-year financial report, January 1 - June 30, 202..
AQ
06/26REVENIO GROUP CORPORATION : Managers' Transactions
AQ
06/11REVENIO GROUP CORPORATION : Revenio's CEO has taken out a loan granted by the co..
AQ
More news
News in other languages on REVENIO GROUP OYJ
01/15REVENIO GROUP OYJ : une autorisation de mise sur le marché fait bondir le titre
2019REVENIO GROUP OYJ : publication des résultats trimestriels
2019REVENIO GROUP OYJ : Veröffentlichung des Quartalsergebnisses
2018REVENIO GROUP OYJ : publication des résultats semestriels
2018REVENIO GROUP OYJ : Veröffentlichung des Halbjahresergebnisses
More news
Chart REVENIO GROUP OYJ
Duration : Period :
Revenio Group Oyj Technical Analysis Chart | REG1V | FI0009010912 | MarketScreener
Technical analysis trends REVENIO GROUP OYJ
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus UNDERPERFORM
Number of Analysts 2
Average target price 36,45 €
Last Close Price 41,40 €
Spread / Highest target -10,9%
Spread / Average Target -12,0%
Spread / Lowest Target -13,0%
EPS Revisions
Managers
NameTitle
Jouni Erik Toijala President & Chief Executive Officer
Pekka Veikko Juhani Rönkä Chairman
Ari Isomäki Operations Director
Robin Allan Pulkkinen Chief Financial Officer
Mika Salkola Director-Research & Development
Sector and Competitors
1st jan.Capitalization (M$)
REVENIO GROUP OYJ57.71%1 327
SARTORIUS AG96.57%29 323
CELLAVISION AB (PUBL)-5.60%846
ALPHATEC HOLDINGS, INC.47.43%820
VAREX IMAGING CORPORATION-45.42%638
OXFORD IMMUNOTEC GLOBAL PLC-11.87%380